Electroporation Potentiated Immunotherapy in Cancer

NCT04835402 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Pancreas Cancer, Metastatic

Interventions

DRUG: Pembrolizumab
DEVICE: Irreversible electroporation

Sponsor

Ole Thorlacius-Ussing, MD, DMSc, Professor of Surgery

Collaborators

[object Object]
[object Object]
[object Object]